Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gender differences in Parkinson's disease.

Lisa M Shulman1

  • 1University of Maryland School of Medicine, Baltimore, MD 21201, USA. LShulman@som.umaryland.edu

Gender Medicine
|June 23, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A fat chance at neuroprotection: Ketogenic diet and Parkinson's disease.

Clinical nutrition ESPEN·2026
Same author

Prospective longitudinal observational study at an academic medical centre of lifestyle and cognition in older adults with a cochlear implant or hearing aid: study protocol.

BMJ open·2026
Same author

Effects of Age and Cognitive Impairment on PROMIS-57 Profile Responses: Qualitative Analyses from Cognitive Interviews.

Advances in patient-reported outcomes·2026
Same author

Recruitment strategies for the racial disparities in Parkinson's disease study: Partnering with patients from the Black community.

Parkinsonism & related disorders·2026
Same author

Large-scale genetic characterization of Parkinson's disease in the African and African admixed populations.

Brain : a journal of neurology·2025
Same author

Longitudinal patterns of loss of independence in Parkinson disease.

Neurodegenerative disease management·2025
Same journal

Sex differences in the biomechanics and contractility of intramural coronary arteries in angiotensin II-induced hypertension.

Gender medicine·2012
Same journal

Effect of sex on lifespan, disease progression, and the response to methionine sulfoximine in the SOD1 G93A mouse model for ALS.

Gender medicine·2012
Same journal

Gender differences in Latin-American patients with rheumatoid arthritis.

Gender medicine·2012
Same journal

Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2500 patients with urothelial carcinoma of the bladder.

Gender medicine·2012
Same journal

Newborns of preeclamptic women show evidence of sex-specific disparity in fetal growth.

Gender medicine·2012
Same journal

The end of an era: the final chapter of Gender Medicine.

Gender medicine·2012
See all related articles

Estrogen replacement therapy may improve Parkinson's disease symptoms in women. The POETRY study suggests ERT could reduce medication needs and enhance quality of life for women with PD.

Area of Science:

  • Neuroscience
  • Endocrinology
  • Movement Disorders

Background:

  • Estrogen influences dopamine neurotransmission, a key factor in Parkinson's disease (PD).
  • PD incidence is higher in men, and estrogen shows neuroprotective effects in animal models.
  • Existing research on estrogen replacement therapy (ERT) for PD risk and neuroprotection yields mixed results.

Purpose of the Study:

  • To investigate the potential of ERT in managing Parkinson's disease symptoms.
  • To explore gender-specific differences in PD progression and treatment response.
  • To evaluate ERT's impact on disability and quality of life in women with PD.

Main Methods:

  • Review of existing research on estrogen and PD.
  • Analysis of gender differences in PD neurotoxicity and levodopa metabolism.

Related Experiment Videos

  • Examination of results from the Parkinson's Disease on Estrogen Therapy Replacement in the Menopause Years (POETRY) study.

    • Main Results:

    • Women with PD report greater disability and reduced quality of life.
    • Women exhibit different levodopa metabolism, impacting treatment efficacy.
    • The POETRY study indicated improved Unified Parkinson Disease Rating Scale scores with ERT.

    Conclusions:

    • ERT may offer symptomatic improvement for women with Parkinson's disease.
    • Estrogen replacement therapy presents a potential strategy to reduce antiparkinsonian medication dosage in women.
    • Further research is warranted to confirm ERT's therapeutic benefits in PD management.